Duramed (DRMD) Synthetic Estrogen Product Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Thure Meyer who wrote (1700)	9/6/2000 4:47:17 PM
From: vestor	Read Replies (1) of 1837

Given the climate surrounding what some innovator drug companies have done to keep out competition with the side effect being higher prices to the consumer, a jury trial is indeed the best forum for the outcome to be determined. Juries, should they find that they themselves have been had, may severly punish the offender monetarily. Jurors know this may be their only chance to send a message that such conduct will be very expensive to the offender. I agree with you 200% and applaud that DRMD is seeking a jury decision as opposed to say a three judge panel or binding arbitration. Given the stock float, if DRMD wins shareholders will benefit greatly and the company will wipeout its debt and have a nice pot of money to pursue further opportunities and the retraints orchestrated by the subject contracts will be ruled void and thus "C" sales will be allowed to compete with Premarin fairly. I believe thus Cenestin sales will improve dramatically. i just hope that the DRMD legal team has gathered sufficient evidence and are good at what they do. Based on their recent performance I believe they are up to the task at hand.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next